Market Overview

UPDATE: Jefferies Raises PT to $65 on CME Group on Long-Term Outlook

Share:
Related CME
CME Group, Multi Commodity Exchange of India sign MoU
Goldman Sachs Downgrades Ameriprise Financial, Virtus On 'Weak Flows' And Retail Risks
CBOE Holdings Q2 Earnings Beat as Topline Rises; Ups Dividend - Analyst Blog (Zacks)

Jefferies reiterated its Buy rating on CME Group (NASDAQ: CME) and raised its price target from $60 to $65.

Jefferies noted, "Last week we spent several days with the management team of CME Group. The focus of the meetings centered around OTC clearing and execution initiatives and the globalization of CME's products, all of which represent potential offsets to the current lackluster environment for trading. On a longer-term basis we see several structural changes that should drive accelerating growth at CME."

CME Group closed at $57.29 on Friday.

Latest Ratings for CME

DateFirmActionFromTo
Jul 2015Keefe Bruyette & WoodsMaintainsMarket Perform
Jul 2015BarclaysMaintainsEqual-weight
Jul 2015UBSMaintainsBuy

View More Analyst Ratings for CME
View the Latest Analyst Ratings

Posted-In: JefferiesAnalyst Color Price Target Intraday Update Analyst Ratings

 

Related Articles (CME)

Get Benzinga's Newsletters